nodes	percent_of_prediction	percent_of_DWPC	metapath
Azithromycin—CYP1A2—chronic obstructive pulmonary disease	0.39	1	CbGaD
Azithromycin—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0975	0.21	CbGbCtD
Azithromycin—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0975	0.21	CbGbCtD
Azithromycin—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0739	0.159	CbGbCtD
Azithromycin—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0434	0.0936	CbGbCtD
Azithromycin—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0316	0.0683	CbGbCtD
Azithromycin—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0257	0.0555	CbGbCtD
Azithromycin—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0174	0.0375	CbGbCtD
Azithromycin—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0166	0.0358	CbGbCtD
Azithromycin—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0148	0.0319	CbGbCtD
Azithromycin—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0145	0.0312	CbGbCtD
Azithromycin—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0137	0.0295	CbGbCtD
Azithromycin—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00867	0.0187	CbGbCtD
Azithromycin—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00819	0.0177	CbGbCtD
Azithromycin—CYP1A2—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.0013	0.0651	CbGpPWpGaD
Azithromycin—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00113	0.0569	CbGpPWpGaD
Azithromycin—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.001	0.0503	CbGpPWpGaD
Azithromycin—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.000819	0.0411	CbGpPWpGaD
Azithromycin—Roxithromycin—CYP1A2—chronic obstructive pulmonary disease	0.000797	0.294	CrCbGaD
Azithromycin—Telithromycin—CYP1A2—chronic obstructive pulmonary disease	0.000775	0.286	CrCbGaD
Azithromycin—Clarithromycin—CYP1A2—chronic obstructive pulmonary disease	0.000604	0.223	CrCbGaD
Azithromycin—CYP2A6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000586	0.0294	CbGpPWpGaD
Azithromycin—Erythromycin—CYP1A2—chronic obstructive pulmonary disease	0.000532	0.196	CrCbGaD
Azithromycin—CYP2A6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00049	0.0246	CbGpPWpGaD
Azithromycin—CYP2A6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000471	0.0236	CbGpPWpGaD
Azithromycin—CYP2A6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000425	0.0213	CbGpPWpGaD
Azithromycin—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000416	0.0209	CbGpPWpGaD
Azithromycin—CYP1A2—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000413	0.0207	CbGpPWpGaD
Azithromycin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—chronic obstructive pulmonary disease	0.000382	0.0191	CbGpPWpGaD
Azithromycin—CYP2A6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000356	0.0179	CbGpPWpGaD
Azithromycin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000352	0.0177	CbGpPWpGaD
Azithromycin—CYP2A6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000342	0.0172	CbGpPWpGaD
Azithromycin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00032	0.0161	CbGpPWpGaD
Azithromycin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000319	0.016	CbGpPWpGaD
Azithromycin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000247	0.0124	CbGpPWpGaD
Azithromycin—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000239	0.012	CbGpPWpGaD
Azithromycin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000215	0.0108	CbGpPWpGaD
Azithromycin—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000203	0.0102	CbGpPWpGaD
Azithromycin—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000202	0.0101	CbGpPWpGaD
Azithromycin—CYP2A6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000201	0.0101	CbGpPWpGaD
Azithromycin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—chronic obstructive pulmonary disease	0.000199	0.01	CbGpPWpGaD
Azithromycin—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000198	0.00161	CcSEcCtD
Azithromycin—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000198	0.00161	CcSEcCtD
Azithromycin—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.00161	CcSEcCtD
Azithromycin—Cough—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00159	CcSEcCtD
Azithromycin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000196	0.00159	CcSEcCtD
Azithromycin—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.00158	CcSEcCtD
Azithromycin—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000196	0.00158	CcSEcCtD
Azithromycin—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.00158	CcSEcCtD
Azithromycin—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.00158	CcSEcCtD
Azithromycin—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.00158	CcSEcCtD
Azithromycin—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000196	0.00158	CcSEcCtD
Azithromycin—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000196	0.00158	CcSEcCtD
Azithromycin—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000195	0.0098	CbGpPWpGaD
Azithromycin—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000195	0.00158	CcSEcCtD
Azithromycin—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.00158	CcSEcCtD
Azithromycin—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000195	0.00158	CcSEcCtD
Azithromycin—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00158	CcSEcCtD
Azithromycin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000195	0.00158	CcSEcCtD
Azithromycin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000195	0.00158	CcSEcCtD
Azithromycin—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00158	CcSEcCtD
Azithromycin—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000194	0.00974	CbGpPWpGaD
Azithromycin—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000193	0.00157	CcSEcCtD
Azithromycin—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000193	0.00157	CcSEcCtD
Azithromycin—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.00155	CcSEcCtD
Azithromycin—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000192	0.00155	CcSEcCtD
Azithromycin—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000192	0.00155	CcSEcCtD
Azithromycin—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000191	0.00155	CcSEcCtD
Azithromycin—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000191	0.00155	CcSEcCtD
Azithromycin—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000191	0.00155	CcSEcCtD
Azithromycin—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.00154	CcSEcCtD
Azithromycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000191	0.00957	CbGpPWpGaD
Azithromycin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00019	0.00154	CcSEcCtD
Azithromycin—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00153	CcSEcCtD
Azithromycin—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000189	0.00153	CcSEcCtD
Azithromycin—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000188	0.00152	CcSEcCtD
Azithromycin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000188	0.00152	CcSEcCtD
Azithromycin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000188	0.00152	CcSEcCtD
Azithromycin—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000188	0.00152	CcSEcCtD
Azithromycin—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00152	CcSEcCtD
Azithromycin—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000187	0.00939	CbGpPWpGaD
Azithromycin—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000186	0.00151	CcSEcCtD
Azithromycin—Infection—Formoterol—chronic obstructive pulmonary disease	0.000186	0.00151	CcSEcCtD
Azithromycin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.0015	CcSEcCtD
Azithromycin—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.0015	CcSEcCtD
Azithromycin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.0015	CcSEcCtD
Azithromycin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000185	0.0015	CcSEcCtD
Azithromycin—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00149	CcSEcCtD
Azithromycin—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000184	0.00923	CbGpPWpGaD
Azithromycin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000184	0.00149	CcSEcCtD
Azithromycin—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000184	0.00149	CcSEcCtD
Azithromycin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000184	0.00149	CcSEcCtD
Azithromycin—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.00148	CcSEcCtD
Azithromycin—Infection—Montelukast—chronic obstructive pulmonary disease	0.000183	0.00148	CcSEcCtD
Azithromycin—CYP2A6—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000182	0.00914	CbGpPWpGaD
Azithromycin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000182	0.00147	CcSEcCtD
Azithromycin—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.00146	CcSEcCtD
Azithromycin—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.00018	0.00146	CcSEcCtD
Azithromycin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00018	0.00146	CcSEcCtD
Azithromycin—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00018	0.00901	CbGpPWpGaD
Azithromycin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.00143	CcSEcCtD
Azithromycin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.00143	CcSEcCtD
Azithromycin—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00142	CcSEcCtD
Azithromycin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000175	0.00142	CcSEcCtD
Azithromycin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000175	0.00142	CcSEcCtD
Azithromycin—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000175	0.00142	CcSEcCtD
Azithromycin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000174	0.00141	CcSEcCtD
Azithromycin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00141	CcSEcCtD
Azithromycin—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000173	0.00867	CbGpPWpGaD
Azithromycin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000171	0.00139	CcSEcCtD
Azithromycin—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.00139	CcSEcCtD
Azithromycin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.00138	CcSEcCtD
Azithromycin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000171	0.00138	CcSEcCtD
Azithromycin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00017	0.00137	CcSEcCtD
Azithromycin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00017	0.00137	CcSEcCtD
Azithromycin—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000169	0.00848	CbGpPWpGaD
Azithromycin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00137	CcSEcCtD
Azithromycin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000169	0.00137	CcSEcCtD
Azithromycin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000167	0.00136	CcSEcCtD
Azithromycin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00135	CcSEcCtD
Azithromycin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00135	CcSEcCtD
Azithromycin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00135	CcSEcCtD
Azithromycin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00135	CcSEcCtD
Azithromycin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000166	0.00135	CcSEcCtD
Azithromycin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.00134	CcSEcCtD
Azithromycin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000165	0.00134	CcSEcCtD
Azithromycin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000165	0.00134	CcSEcCtD
Azithromycin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000165	0.00134	CcSEcCtD
Azithromycin—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000165	0.00827	CbGpPWpGaD
Azithromycin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000164	0.00133	CcSEcCtD
Azithromycin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000163	0.00132	CcSEcCtD
Azithromycin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000163	0.00132	CcSEcCtD
Azithromycin—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000163	0.00816	CbGpPWpGaD
Azithromycin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00131	CcSEcCtD
Azithromycin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00131	CcSEcCtD
Azithromycin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000162	0.00131	CcSEcCtD
Azithromycin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00131	CcSEcCtD
Azithromycin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00131	CcSEcCtD
Azithromycin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.00131	CcSEcCtD
Azithromycin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.0013	CcSEcCtD
Azithromycin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00016	0.0013	CcSEcCtD
Azithromycin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.0013	CcSEcCtD
Azithromycin—Pain—Formoterol—chronic obstructive pulmonary disease	0.00016	0.0013	CcSEcCtD
Azithromycin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.0013	CcSEcCtD
Azithromycin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.00129	CcSEcCtD
Azithromycin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000159	0.00128	CcSEcCtD
Azithromycin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000158	0.00128	CcSEcCtD
Azithromycin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00128	CcSEcCtD
Azithromycin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.00128	CcSEcCtD
Azithromycin—Pain—Montelukast—chronic obstructive pulmonary disease	0.000157	0.00127	CcSEcCtD
Azithromycin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000157	0.00127	CcSEcCtD
Azithromycin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000156	0.00783	CbGpPWpGaD
Azithromycin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.00126	CcSEcCtD
Azithromycin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000155	0.00126	CcSEcCtD
Azithromycin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000155	0.00126	CcSEcCtD
Azithromycin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00125	CcSEcCtD
Azithromycin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00125	CcSEcCtD
Azithromycin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000154	0.00125	CcSEcCtD
Azithromycin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.00125	CcSEcCtD
Azithromycin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000154	0.00124	CcSEcCtD
Azithromycin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.00124	CcSEcCtD
Azithromycin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000153	0.00124	CcSEcCtD
Azithromycin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00124	CcSEcCtD
Azithromycin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00124	CcSEcCtD
Azithromycin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.00123	CcSEcCtD
Azithromycin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.00123	CcSEcCtD
Azithromycin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00015	0.00122	CcSEcCtD
Azithromycin—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00015	0.00751	CbGpPWpGaD
Azithromycin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000149	0.00121	CcSEcCtD
Azithromycin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.00121	CcSEcCtD
Azithromycin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.0012	CcSEcCtD
Azithromycin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000148	0.0012	CcSEcCtD
Azithromycin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.0012	CcSEcCtD
Azithromycin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000148	0.0012	CcSEcCtD
Azithromycin—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000148	0.00742	CbGpPWpGaD
Azithromycin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000148	0.0012	CcSEcCtD
Azithromycin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.00119	CcSEcCtD
Azithromycin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000146	0.00119	CcSEcCtD
Azithromycin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000146	0.00119	CcSEcCtD
Azithromycin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000146	0.00118	CcSEcCtD
Azithromycin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00118	CcSEcCtD
Azithromycin—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000146	0.00732	CbGpPWpGaD
Azithromycin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000146	0.00118	CcSEcCtD
Azithromycin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000145	0.00118	CcSEcCtD
Azithromycin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000145	0.00118	CcSEcCtD
Azithromycin—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00117	CcSEcCtD
Azithromycin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.00117	CcSEcCtD
Azithromycin—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00116	CcSEcCtD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000142	0.00713	CbGpPWpGaD
Azithromycin—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000142	0.00712	CbGpPWpGaD
Azithromycin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.00114	CcSEcCtD
Azithromycin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.00113	CcSEcCtD
Azithromycin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.00113	CcSEcCtD
Azithromycin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000138	0.00112	CcSEcCtD
Azithromycin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000138	0.00112	CcSEcCtD
Azithromycin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000138	0.00112	CcSEcCtD
Azithromycin—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000138	0.00112	CcSEcCtD
Azithromycin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000135	0.0011	CcSEcCtD
Azithromycin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.00109	CcSEcCtD
Azithromycin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000135	0.00109	CcSEcCtD
Azithromycin—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000134	0.00673	CbGpPWpGaD
Azithromycin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000133	0.00107	CcSEcCtD
Azithromycin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000133	0.00107	CcSEcCtD
Azithromycin—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000132	0.00107	CcSEcCtD
Azithromycin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000132	0.00107	CcSEcCtD
Azithromycin—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00013	0.00655	CbGpPWpGaD
Azithromycin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.00106	CcSEcCtD
Azithromycin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00013	0.00105	CcSEcCtD
Azithromycin—CYP2A6—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.00013	0.00652	CbGpPWpGaD
Azithromycin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.00104	CcSEcCtD
Azithromycin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000128	0.00104	CcSEcCtD
Azithromycin—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.00103	CcSEcCtD
Azithromycin—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00103	CcSEcCtD
Azithromycin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.00103	CcSEcCtD
Azithromycin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000126	0.00102	CcSEcCtD
Azithromycin—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.0063	CbGpPWpGaD
Azithromycin—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.0063	CbGpPWpGaD
Azithromycin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.00101	CcSEcCtD
Azithromycin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.001	CcSEcCtD
Azithromycin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000124	0.001	CcSEcCtD
Azithromycin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000121	0.000984	CcSEcCtD
Azithromycin—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000983	CcSEcCtD
Azithromycin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.000981	CcSEcCtD
Azithromycin—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00012	0.00601	CbGpPWpGaD
Azithromycin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.000966	CcSEcCtD
Azithromycin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000119	0.000966	CcSEcCtD
Azithromycin—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000119	0.00597	CbGpPWpGaD
Azithromycin—CYP2A6—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000119	0.00596	CbGpPWpGaD
Azithromycin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.000958	CcSEcCtD
Azithromycin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000118	0.000958	CcSEcCtD
Azithromycin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000118	0.000957	CcSEcCtD
Azithromycin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.000957	CcSEcCtD
Azithromycin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.000952	CcSEcCtD
Azithromycin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000118	0.000952	CcSEcCtD
Azithromycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000117	0.00589	CbGpPWpGaD
Azithromycin—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.00095	CcSEcCtD
Azithromycin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.000949	CcSEcCtD
Azithromycin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000117	0.000946	CcSEcCtD
Azithromycin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000116	0.000938	CcSEcCtD
Azithromycin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000116	0.000937	CcSEcCtD
Azithromycin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000935	CcSEcCtD
Azithromycin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000115	0.000932	CcSEcCtD
Azithromycin—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000921	CcSEcCtD
Azithromycin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.000912	CcSEcCtD
Azithromycin—CYP2A6—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000113	0.00565	CbGpPWpGaD
Azithromycin—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000909	CcSEcCtD
Azithromycin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000906	CcSEcCtD
Azithromycin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000904	CcSEcCtD
Azithromycin—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000904	CcSEcCtD
Azithromycin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000904	CcSEcCtD
Azithromycin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.000902	CcSEcCtD
Azithromycin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000111	0.000902	CcSEcCtD
Azithromycin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000899	CcSEcCtD
Azithromycin—CYP2A6—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.00011	0.00554	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.00011	0.0055	CbGpPWpGaD
Azithromycin—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000886	CcSEcCtD
Azithromycin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000109	0.000884	CcSEcCtD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000109	0.00545	CbGpPWpGaD
Azithromycin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000873	CcSEcCtD
Azithromycin—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.00087	CcSEcCtD
Azithromycin—CYP2A6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000105	0.00529	CbGpPWpGaD
Azithromycin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.000852	CcSEcCtD
Azithromycin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000848	CcSEcCtD
Azithromycin—CYP2A6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000104	0.00523	CbGpPWpGaD
Azithromycin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000823	CcSEcCtD
Azithromycin—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000823	CcSEcCtD
Azithromycin—Shock—Prednisolone—chronic obstructive pulmonary disease	9.99e-05	0.000809	CcSEcCtD
Azithromycin—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	9.88e-05	0.00496	CbGpPWpGaD
Azithromycin—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	9.82e-05	0.000795	CcSEcCtD
Azithromycin—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	9.28e-05	0.000752	CcSEcCtD
Azithromycin—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	9.23e-05	0.00463	CbGpPWpGaD
Azithromycin—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	9.22e-05	0.00463	CbGpPWpGaD
Azithromycin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	9.19e-05	0.000744	CcSEcCtD
Azithromycin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	9.12e-05	0.000739	CcSEcCtD
Azithromycin—CYP2A6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.76e-05	0.00439	CbGpPWpGaD
Azithromycin—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	8.7e-05	0.00436	CbGpPWpGaD
Azithromycin—Pain—Prednisolone—chronic obstructive pulmonary disease	8.69e-05	0.000704	CcSEcCtD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	8.68e-05	0.00436	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	8.68e-05	0.00436	CbGpPWpGaD
Azithromycin—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.68e-05	0.00436	CbGpPWpGaD
Azithromycin—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	8.56e-05	0.00429	CbGpPWpGaD
Azithromycin—Vision blurred—Prednisone—chronic obstructive pulmonary disease	8.52e-05	0.00069	CcSEcCtD
Azithromycin—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	8.46e-05	0.00424	CbGpPWpGaD
Azithromycin—CYP2A6—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	8.44e-05	0.00423	CbGpPWpGaD
Azithromycin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	8.39e-05	0.00068	CcSEcCtD
Azithromycin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	8.37e-05	0.000678	CcSEcCtD
Azithromycin—Anaemia—Prednisone—chronic obstructive pulmonary disease	8.36e-05	0.000677	CcSEcCtD
Azithromycin—CYP2A6—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	8.33e-05	0.00418	CbGpPWpGaD
Azithromycin—Agitation—Prednisone—chronic obstructive pulmonary disease	8.31e-05	0.000673	CcSEcCtD
Azithromycin—Angioedema—Prednisone—chronic obstructive pulmonary disease	8.26e-05	0.000669	CcSEcCtD
Azithromycin—CYP2A6—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	8.21e-05	0.00412	CbGpPWpGaD
Azithromycin—Malaise—Prednisone—chronic obstructive pulmonary disease	8.16e-05	0.000661	CcSEcCtD
Azithromycin—Vertigo—Prednisone—chronic obstructive pulmonary disease	8.13e-05	0.000658	CcSEcCtD
Azithromycin—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	8.12e-05	0.00408	CbGpPWpGaD
Azithromycin—Syncope—Prednisone—chronic obstructive pulmonary disease	8.11e-05	0.000657	CcSEcCtD
Azithromycin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	8.07e-05	0.000654	CcSEcCtD
Azithromycin—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	7.98e-05	0.004	CbGpPWpGaD
Azithromycin—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	7.95e-05	0.000644	CcSEcCtD
Azithromycin—Convulsion—Prednisone—chronic obstructive pulmonary disease	7.84e-05	0.000635	CcSEcCtD
Azithromycin—Hypertension—Prednisone—chronic obstructive pulmonary disease	7.81e-05	0.000632	CcSEcCtD
Azithromycin—Myalgia—Prednisone—chronic obstructive pulmonary disease	7.7e-05	0.000624	CcSEcCtD
Azithromycin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	7.7e-05	0.000624	CcSEcCtD
Azithromycin—Anxiety—Prednisone—chronic obstructive pulmonary disease	7.67e-05	0.000621	CcSEcCtD
Azithromycin—CYP2A6—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	7.65e-05	0.00384	CbGpPWpGaD
Azithromycin—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	7.63e-05	0.00383	CbGpPWpGaD
Azithromycin—Discomfort—Prednisone—chronic obstructive pulmonary disease	7.61e-05	0.000616	CcSEcCtD
Azithromycin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.48e-05	0.000606	CcSEcCtD
Azithromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	7.46e-05	0.00374	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	7.45e-05	0.00374	CbGpPWpGaD
Azithromycin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	7.38e-05	0.000598	CcSEcCtD
Azithromycin—Oedema—Prednisone—chronic obstructive pulmonary disease	7.38e-05	0.000598	CcSEcCtD
Azithromycin—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	7.36e-05	0.00369	CbGpPWpGaD
Azithromycin—Infection—Prednisone—chronic obstructive pulmonary disease	7.33e-05	0.000594	CcSEcCtD
Azithromycin—CYP2A6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.31e-05	0.00367	CbGpPWpGaD
Azithromycin—Shock—Prednisone—chronic obstructive pulmonary disease	7.26e-05	0.000588	CcSEcCtD
Azithromycin—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	7.14e-05	0.000578	CcSEcCtD
Azithromycin—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	7.11e-05	0.00357	CbGpPWpGaD
Azithromycin—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	7.07e-05	0.00355	CbGpPWpGaD
Azithromycin—Anorexia—Prednisone—chronic obstructive pulmonary disease	7.04e-05	0.00057	CcSEcCtD
Azithromycin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.02e-05	0.00352	CbGpPWpGaD
Azithromycin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.93e-05	0.00348	CbGpPWpGaD
Azithromycin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	6.73e-05	0.000545	CcSEcCtD
Azithromycin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.72e-05	0.000544	CcSEcCtD
Azithromycin—CYP2A6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.71e-05	0.00337	CbGpPWpGaD
Azithromycin—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	6.7e-05	0.00336	CbGpPWpGaD
Azithromycin—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.68e-05	0.000541	CcSEcCtD
Azithromycin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.63e-05	0.000537	CcSEcCtD
Azithromycin—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	6.59e-05	0.00331	CbGpPWpGaD
Azithromycin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.5e-05	0.000526	CcSEcCtD
Azithromycin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	6.42e-05	0.00052	CcSEcCtD
Azithromycin—Rash—Prednisolone—chronic obstructive pulmonary disease	6.4e-05	0.000519	CcSEcCtD
Azithromycin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.4e-05	0.000518	CcSEcCtD
Azithromycin—CYP2A6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.36e-05	0.00319	CbGpPWpGaD
Azithromycin—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.36e-05	0.000515	CcSEcCtD
Azithromycin—Headache—Prednisolone—chronic obstructive pulmonary disease	6.36e-05	0.000515	CcSEcCtD
Azithromycin—Constipation—Prednisone—chronic obstructive pulmonary disease	6.31e-05	0.000511	CcSEcCtD
Azithromycin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.08e-05	0.000493	CcSEcCtD
Azithromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.05e-05	0.00303	CbGpPWpGaD
Azithromycin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	6.04e-05	0.000489	CcSEcCtD
Azithromycin—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.03e-05	0.000489	CcSEcCtD
Azithromycin—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	5.93e-05	0.00298	CbGpPWpGaD
Azithromycin—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.86e-05	0.000475	CcSEcCtD
Azithromycin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.84e-05	0.000473	CcSEcCtD
Azithromycin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.84e-05	0.000473	CcSEcCtD
Azithromycin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.69e-05	0.00286	CbGpPWpGaD
Azithromycin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	5.55e-05	0.00278	CbGpPWpGaD
Azithromycin—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	5.45e-05	0.00274	CbGpPWpGaD
Azithromycin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.44e-05	0.00044	CcSEcCtD
Azithromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.42e-05	0.00272	CbGpPWpGaD
Azithromycin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.35e-05	0.00268	CbGpPWpGaD
Azithromycin—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.3e-05	0.000429	CcSEcCtD
Azithromycin—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.22e-05	0.000423	CcSEcCtD
Azithromycin—CYP2A6—Metabolism—APIP—chronic obstructive pulmonary disease	5.12e-05	0.00257	CbGpPWpGaD
Azithromycin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.05e-05	0.000409	CcSEcCtD
Azithromycin—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.01e-05	0.00251	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.95e-05	0.00248	CbGpPWpGaD
Azithromycin—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.88e-05	0.000395	CcSEcCtD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	4.8e-05	0.00241	CbGpPWpGaD
Azithromycin—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.69e-05	0.00038	CcSEcCtD
Azithromycin—Rash—Prednisone—chronic obstructive pulmonary disease	4.65e-05	0.000377	CcSEcCtD
Azithromycin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.65e-05	0.000377	CcSEcCtD
Azithromycin—Headache—Prednisone—chronic obstructive pulmonary disease	4.62e-05	0.000375	CcSEcCtD
Azithromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.39e-05	0.0022	CbGpPWpGaD
Azithromycin—Nausea—Prednisone—chronic obstructive pulmonary disease	4.38e-05	0.000355	CcSEcCtD
Azithromycin—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	4.07e-05	0.00204	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.07e-05	0.00204	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	3.91e-05	0.00196	CbGpPWpGaD
Azithromycin—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.86e-05	0.00194	CbGpPWpGaD
Azithromycin—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.82e-05	0.00192	CbGpPWpGaD
Azithromycin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	3.82e-05	0.00192	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	3.73e-05	0.00187	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.66e-05	0.00184	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.66e-05	0.00184	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.52e-05	0.00177	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.49e-05	0.00175	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.49e-05	0.00175	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.47e-05	0.00174	CbGpPWpGaD
Azithromycin—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.42e-05	0.00172	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.39e-05	0.0017	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	3.31e-05	0.00166	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	3.3e-05	0.00166	CbGpPWpGaD
Azithromycin—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.21e-05	0.00161	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.19e-05	0.0016	CbGpPWpGaD
Azithromycin—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.17e-05	0.00159	CbGpPWpGaD
Azithromycin—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.15e-05	0.00158	CbGpPWpGaD
Azithromycin—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	3.12e-05	0.00157	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.07e-05	0.00154	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	3.05e-05	0.00153	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	3.03e-05	0.00152	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.02e-05	0.00152	CbGpPWpGaD
Azithromycin—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.98e-05	0.0015	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	2.83e-05	0.00142	CbGpPWpGaD
Azithromycin—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.68e-05	0.00134	CbGpPWpGaD
Azithromycin—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.64e-05	0.00133	CbGpPWpGaD
Azithromycin—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.46e-05	0.00124	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.43e-05	0.00122	CbGpPWpGaD
Azithromycin—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.43e-05	0.00122	CbGpPWpGaD
Azithromycin—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.33e-05	0.00117	CbGpPWpGaD
Azithromycin—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.3e-05	0.00115	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.02e-05	0.00101	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.96e-05	0.000985	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.88e-05	0.000942	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.83e-05	0.000916	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.8e-05	0.000904	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.78e-05	0.000894	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.73e-05	0.00087	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.63e-05	0.000819	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.63e-05	0.000816	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.61e-05	0.000808	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.57e-05	0.000786	CbGpPWpGaD
Azithromycin—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.57e-05	0.000785	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.5e-05	0.000752	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.5e-05	0.000751	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.47e-05	0.000737	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.46e-05	0.000731	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.4e-05	0.000702	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.25e-05	0.000627	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.24e-05	0.000624	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.23e-05	0.000619	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.23e-05	0.000618	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.21e-05	0.000607	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.16e-05	0.000583	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.15e-05	0.000576	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.12e-05	0.000564	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.09e-05	0.000546	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.07e-05	0.000538	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.06e-05	0.000532	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.68e-06	0.000485	CbGpPWpGaD
Azithromycin—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.4e-06	0.000472	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.91e-06	0.000447	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.56e-06	0.00043	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	8.46e-06	0.000425	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.89e-06	0.000396	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.72e-06	0.000388	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.44e-06	0.000373	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	7.4e-06	0.000371	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.33e-06	0.000368	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.08e-06	0.000355	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.83e-06	0.000343	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.61e-06	0.000332	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.53e-06	0.000328	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.48e-06	0.000325	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.96e-06	0.000299	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.94e-06	0.000298	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.85e-06	0.000294	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.49e-06	0.000276	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.45e-06	0.000274	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.17e-06	0.000259	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.58e-06	0.00023	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.52e-06	0.000227	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.4e-06	0.000221	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.21e-06	0.000211	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.21e-06	0.000211	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.99e-06	0.0002	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.51e-06	0.000176	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.36e-06	0.000169	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.71e-06	0.000136	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.59e-06	0.00013	CbGpPWpGaD
